Cargando…

Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort

Detalles Bibliográficos
Autores principales: Costello, R. E., Humphreys, J. H., Sergeant, J. C., Haris, M., Stirling, F., Raza, K., van Schaardenburg, D., Bruce, Ian N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524988/
https://www.ncbi.nlm.nih.gov/pubmed/34666823
http://dx.doi.org/10.1186/s13075-021-02645-1
_version_ 1784585585165336576
author Costello, R. E.
Humphreys, J. H.
Sergeant, J. C.
Haris, M.
Stirling, F.
Raza, K.
van Schaardenburg, D.
Bruce, Ian N.
author_facet Costello, R. E.
Humphreys, J. H.
Sergeant, J. C.
Haris, M.
Stirling, F.
Raza, K.
van Schaardenburg, D.
Bruce, Ian N.
author_sort Costello, R. E.
collection PubMed
description
format Online
Article
Text
id pubmed-8524988
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85249882021-10-22 Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort Costello, R. E. Humphreys, J. H. Sergeant, J. C. Haris, M. Stirling, F. Raza, K. van Schaardenburg, D. Bruce, Ian N. Arthritis Res Ther Correction BioMed Central 2021-10-19 2021 /pmc/articles/PMC8524988/ /pubmed/34666823 http://dx.doi.org/10.1186/s13075-021-02645-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Costello, R. E.
Humphreys, J. H.
Sergeant, J. C.
Haris, M.
Stirling, F.
Raza, K.
van Schaardenburg, D.
Bruce, Ian N.
Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort
title Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort
title_full Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort
title_fullStr Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort
title_full_unstemmed Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort
title_short Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort
title_sort correction to: symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (sparra) questionnaire in the preclinical evaluation of novel targets in ra (prevent-ra) cohort
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524988/
https://www.ncbi.nlm.nih.gov/pubmed/34666823
http://dx.doi.org/10.1186/s13075-021-02645-1
work_keys_str_mv AT costellore correctiontosymptomsinfirstdegreerelativesofpatientswithrheumatoidarthritisevaluationofcrosssectionaldatafromthesymptomsinpersonsatriskofrheumatoidarthritissparraquestionnaireinthepreclinicalevaluationofnoveltargetsinrapreventracohort
AT humphreysjh correctiontosymptomsinfirstdegreerelativesofpatientswithrheumatoidarthritisevaluationofcrosssectionaldatafromthesymptomsinpersonsatriskofrheumatoidarthritissparraquestionnaireinthepreclinicalevaluationofnoveltargetsinrapreventracohort
AT sergeantjc correctiontosymptomsinfirstdegreerelativesofpatientswithrheumatoidarthritisevaluationofcrosssectionaldatafromthesymptomsinpersonsatriskofrheumatoidarthritissparraquestionnaireinthepreclinicalevaluationofnoveltargetsinrapreventracohort
AT harism correctiontosymptomsinfirstdegreerelativesofpatientswithrheumatoidarthritisevaluationofcrosssectionaldatafromthesymptomsinpersonsatriskofrheumatoidarthritissparraquestionnaireinthepreclinicalevaluationofnoveltargetsinrapreventracohort
AT stirlingf correctiontosymptomsinfirstdegreerelativesofpatientswithrheumatoidarthritisevaluationofcrosssectionaldatafromthesymptomsinpersonsatriskofrheumatoidarthritissparraquestionnaireinthepreclinicalevaluationofnoveltargetsinrapreventracohort
AT razak correctiontosymptomsinfirstdegreerelativesofpatientswithrheumatoidarthritisevaluationofcrosssectionaldatafromthesymptomsinpersonsatriskofrheumatoidarthritissparraquestionnaireinthepreclinicalevaluationofnoveltargetsinrapreventracohort
AT vanschaardenburgd correctiontosymptomsinfirstdegreerelativesofpatientswithrheumatoidarthritisevaluationofcrosssectionaldatafromthesymptomsinpersonsatriskofrheumatoidarthritissparraquestionnaireinthepreclinicalevaluationofnoveltargetsinrapreventracohort
AT bruceiann correctiontosymptomsinfirstdegreerelativesofpatientswithrheumatoidarthritisevaluationofcrosssectionaldatafromthesymptomsinpersonsatriskofrheumatoidarthritissparraquestionnaireinthepreclinicalevaluationofnoveltargetsinrapreventracohort